Researchers have discovered a novel cause of cytokine storm -- the extreme inflammatory response associated with increased risk of death in COVID-19 infection.
The global biosimilar monoclonal antibody market revenue was around US$ 10.6 billion in 2023 and is estimated to reach US$ 64.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 22.2 ...